/ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse
NEWS
ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse
PRNewswire
2024/08/27ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse
EVERSANA logo (PRNewsfoto/EVERSANA)
ConTIPI Medical has selected EVERSANA to support the U.S. commercialization of its non-surgical medical device ProVate for women with pelvic organ prolapses.
Summary
/PRNewswire/ -- ConTIPI Medical, an innovator in the field of providing non-surgical and disposable solutions for women with various pelvic floor dysfunctions,...